Would a sale of Cavatak be restricted to melanoma treatment only . What about the other cancers where trials have been carried out and are proposed for the future . As far as I know T-Vec is only being trialled for melanoma . Surely with its wide range of possibilities Cavatak is worth a lot more than T-Vec . Could Cavatak be sold to a number of pharmas for different cancer treatments .